Unique ID issued by UMIN | UMIN000016966 |
---|---|
Receipt number | R000017090 |
Scientific Title | Study of the clinical utility and safety in combination use of the GLI-1 analogue and Insulin degludec in type 2 diabetic patients. |
Date of disclosure of the study information | 2015/03/30 |
Last modified on | 2015/07/22 15:31:14 |
Study of the clinical utility and safety in combination use of the GLI-1 analogue and Insulin degludec in type 2 diabetic patients.
Study of the clinical utility and safety in combination use of the GLI-1 analogue and Insulin degludec in type 2 diabetic patients.
Study of the clinical utility and safety in combination use of the GLI-1 analogue and Insulin degludec in type 2 diabetic patients.
Study of the clinical utility and safety in combination use of the GLI-1 analogue and Insulin degludec in type 2 diabetic patients.
Japan |
Type 2 diabetes
Endocrinology and Metabolism |
Others
NO
The purpose of this study is to assess the effect of combination therapy of liraglutide and insulin degludec on glycemic control and safety in patients with type 2 diabetes.
Safety,Efficacy
change of HbA1c
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Despite while using liraglutide , deterioration in glycemic control , or administered to a patient in weight gain.
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1)Patients with written IC.
2)Patients who use Liraglutide of Deterioration.
3)HbA1c (NGSP):more than 6.2%.
1)Patients with advanced diabetic complications.
2)Patients with to the contraindication of GLP-1 receptor agonist (Victoza subcutaneous injection18mg) (Liraglutide)
3)Patients with to the contraindication of the long acting insulin analog formulation (Tresiba Injection) (Degludec)
4)Patients judged by the investigator to be ineligible for some other reason
30
1st name | |
Middle name | |
Last name | Masao Toyoda |
Department of Internal Medicine, Tokai University School of Medicine
Division of Nephrology, Endocrinology and Metabolism
143 Shimokasuya, Isehara, Kanagawa 259-1193, JAPAN
0563-93-1121
m-toyoda@is.icc.u-tokai.ac.jp
1st name | |
Middle name | |
Last name | Wakana Miura |
Department of Internal Medicine, Tokai University School of Medicine
Division of Nephrology, Endocrinology and Metabolism
143 Shimokasuya, Isehara, Kanagawa 259-1193, JAPAN
0563-93-1121
happy0897@gmail.com
Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine
Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine
Self funding
NO
2015 | Year | 03 | Month | 30 | Day |
Unpublished
Completed
2013 | Year | 06 | Month | 07 | Day |
2013 | Year | 06 | Month | 07 | Day |
2015 | Year | 03 | Month | 30 | Day |
2015 | Year | 07 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017090
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |